USA - engelsk - NLM (National Library of Medicine)

west-ward pharmaceuticals corp. - calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb) - calcium carbonate 1250 mg

USA - engelsk - NLM (National Library of Medicine)

west-ward pharmaceuticals corp - oxytocin (unii: 1jqs135eyn) (oxytocin - unii:1jqs135eyn) - oxytocin 10 [usp'u] in 1 ml - important notice oxytocin injection, usp (synthetic) is indicated for the medical rather than the elective induction of labor. available data and information are inadequate to define the benefits to risks considerations in the use of the drug product for elective induction. elective induction of labor is defined as the initiation of labor for convenience in an individual with a term pregnancy who is free of medical indications. oxytocin injection, usp (synthetic) is indicated for the initiation or improvement of uterine contractions, where this is desirable and considered suitable, in order to achieve early vaginal delivery for fetal or maternal reasons. it is indicated for (1) induction of labor in patients with a medical indication for the initiation of labor, such as rh problems, maternal diabetes, pre-eclampsia at or near term, when delivery is in the best interest of mother and fetus or when membranes are prematurely ruptured and delivery is indicated; (2) stimulation or reinforcement of labor, as in

USA - engelsk - NLM (National Library of Medicine)

west-ward pharmaceuticals corp. - megestrol acetate (unii: tj2m0fr8es) (megestrol - unii:ea6ld1m70m) - megestrol acetate 20 mg - megestrol acetate is indicated for the palliative treatment of advanced carcinoma of the breast or endometrium (i.e., recurrent, inoperable, or metastatic disease). it should not be used in lieu of currently accepted procedures such as surgery, radiation, or chemotherapy. history of hypersensitivity to megestrol acetate or any component of the formulation.

USA - engelsk - NLM (National Library of Medicine)

west-ward pharmaceuticals corp. - magnesium hydroxide (unii: nbz3qy004s) (magnesium cation - unii:t6v3lhy838) - magnesium hydroxide 2400 mg in 10 ml - laxative this product usually produces bowel movement in 1/2 to 6 hours.

USA - engelsk - NLM (National Library of Medicine)

west-ward pharmaceuticals corp - prednisone (unii: vb0r961hzt) (prednisone - unii:vb0r961hzt) - prednisone 5 mg - prednisone tablets, usp are indicated in the following conditions: endocrine disorders primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice: synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance); congenital adrenal hyperplasia; hypercalcemia associated with cancer; nonsuppurative thyroiditis. rheumatic disorders as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: psoriatic arthritis, rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy), ankylosing spondylitis, acute and subacute bursitis, acute nonspecific tenosynovitis, acute gouty arthritis, post-traumatic osteoarthritis, synovitis of osteoarthritis, epicondylitis. collagen diseases during an exacerbation or as maintenance therapy in selected cases of: systemic lupus er

USA - engelsk - NLM (National Library of Medicine)

west-ward pharmaceuticals corp. - azelastine hydrochloride (unii: 0l591qr10i) (azelastine - unii:zqi909440x) - azelastine hydrochloride 137 ug - azelastine hydrochloride nasal spray is indicated for the treatment of the symptoms of seasonal allergic rhinitis in adults and pediatric patients 5 years and older, and for the treatment of the symptoms of vasomotor rhinitis in adults and adolescent patients 12 years and older. none. risk summary limited data from postmarketing experience over decades of use with azelastine hydrochloride in pregnant women have not identified any drug associated risks of miscarriage, birth defects, or other adverse maternal or fetal outcomes. in animal reproduction studies, there was no evidence of fetal harm at oral doses approximately 5 times the clinical daily dose. oral administration of azelastine hydrochloride to pregnant mice, rats, and rabbits, during the period of organogenesis, produced developmental toxicity that included structural abnormalities, decreased embryo-fetal survival, and decreased fetal body weights at doses 270 times and higher than the maximum recommended human daily intranasal dose (mrhdid) of 1.096

USA - engelsk - NLM (National Library of Medicine)

west-ward pharmaceuticals corp. - anastrozole (unii: 2z07myw1az) (anastrozole - unii:2z07myw1az) - anastrozole 1 mg

USA - engelsk - NLM (National Library of Medicine)

west-ward pharmaceuticals corp. - perindopril erbumine (unii: 1964x464oj) (perindoprilat - unii:2uv6znq92k) - perindopril erbumine 2 mg - perindopril erbumine is indicated for the treatment of patients with essential hypertension. perindopril erbumine may be used alone or given with other classes of antihypertensives, especially thiazide diuretics. perindopril erbumine is indicated for treatment of patients with stable coronary artery disease to reduce the risk of cardiovascular mortality or nonfatal myocardial infarction. perindopril erbumine can be used with conventional treatment for management of coronary artery disease, such as antiplatelet, antihypertensive or lipid-lowering therapy. perindopril erbumine is contraindicated in patients known to be hypersensitive (including angioedema) to this product or to any other ace inhibitor. perindopril erbumine is also contraindicated in patients with hereditary or idiopathic angioedema. do not co-administer aliskiren with perindopril erbumine in patients with diabetes [see drug interactions (7.8) ]. perindopril erbumine is contraindicated in combination with neprilysin inhibitor (e.g., sacubitril).

USA - engelsk - NLM (National Library of Medicine)

west-ward pharmaceuticals corp - palonosetron hydrochloride (unii: 23310d4i19) (palonosetron - unii:5d06587d6r) - palonosetron .25 mg in 2 ml - palonosetron hydrochloride (hcl) injection is indicated for: •     moderately emetogenic cancer chemotherapy – prevention of acute and delayed nausea and vomiting associated with initial and repeat courses •     highly emetogenic cancer chemotherapy – prevention of acute nausea and vomiting associated with initial and repeat courses palonosetron hcl injection is contraindicated in patients known to have hypersensitivity to the drug or any of its components [see adverse reactions (6.2)] . r i sk summary there are no available data on palonosetron hcl use in pregnant women to inform a drug-associated risk. in animal reproduction studies, no effects on embryo-fetal development were observed with the administration of oral palonosetron hcl to rats and rabbits during organogenesis at doses up to 1894 and 3789 times the recommended human intravenous dose, respectively [see data]. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown.  in the u.s. general popula

USA - engelsk - NLM (National Library of Medicine)

west-ward pharmaceuticals corp. - megestrol acetate (unii: tj2m0fr8es) (megestrol - unii:ea6ld1m70m) - megestrol acetate 40 mg in 1 ml - megestrol acetate oral suspension is indicated for the treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (aids). history of hypersensitivity to megestrol acetate or any component of the formulation. known or suspected pregnancy.